Navigating the CMA Market Investigation: What SEIS/EIS Investors Need to Know

Why the CMA Market Investigation Matters to SEIS/EIS Investors

The CMA market investigation into investment consultancy and fiduciary management reshaped how early‐stage investors and startups interact. If you’ve ever wondered why transparency, fees and compliance reporting suddenly matter more, this probe is the reason. The Competition and Markets Authority flagged that certain practices might restrict competition, leading to a formal market inquiry in 2017 and a final order in 2019.

That matters for SEIS and EIS players. You want platforms that don’t just list opportunities but live up to new reporting rules and offer clear, upfront fee structures. Oriel IPO has built its marketplace with those rulings in mind. Revolutionizing Investment Opportunities in the UK: Navigating the CMA market investigation


1. A Quick Recap of the Investment Consultancy Market Investigation

The CMA launched its investigation on 14 September 2017 to probe how institutional investors and pension trustees get advice and fiduciary management. By 10 June 2019 the enquiry closed, revealing:

  • Adverse effect on competition: Large consultancies had too much sway, stifling smaller firms and inflating advice costs.
  • Final Order publications: Detailed rules in the Investment Consultancy and Fiduciary Management Market Investigation Order 2019.
  • Compliance reporting: Investment Consultancy Providers, Fiduciary Management Providers and combined IC-FM firms must submit annual statements by 7 January.

Key timeline highlights:

  • November 2016: FCA’s interim Asset Management Market Study suggests a referral.
  • September 2017: Formal market investigation starts.
  • December 2018: Provisional decision report, opening the door for feedback.
  • June 2019: Final Order made, remedies set out.

Trustees once had to file compliance statements under the Order. With the 2022 sunsetting of certain provisions, The Occupational Pension Schemes (Governance and Registration) Amendment Regulations took over. Yet, providers still report directly to the CMA at RemediesMonitoringTeam@cma.gov.uk.


2. Why SEIS/EIS Investors Need to Watch These Developments

For SEIS/EIS investors, smaller deals and early‐stage startups might not seem tied to giant pension funds. But the CMA market investigation still ripples through:

  • Fee transparency: Platforms must clarify what they charge you, cutting hidden margins.
  • Quality assurance: Vetted providers now stand out. That matters when you back an unproven startup.
  • Governance confidence: Firms handling your funds must tick the boxes in reporting, so you know you’re covered.

In practice, this means you avoid surprises. You see clear fee breakdowns and can compare service levels. And you can trust the platform to handle compliance, rather than scrambling through dense Order articles.


3. How Oriel IPO Navigates the Post-Investigation Landscape

Oriel IPO set out to address exactly these pain points. By focusing on SEIS and EIS, our UK-based marketplace empowers you and founders alike:

  • Commission-free funding: No hidden cuts; startups keep more capital.
  • Subscription-based model: Predictable costs for founders, no dips into investment funds.
  • Curated, vetted deals: We screen every opportunity against SEIS/EIS criteria.
  • Educational resources: Guides, webinars and insights on scheme compliance.
  • Transparency first: Straightforward fee disclosures and annual compliance updates.

We built our platform around the lessons from the CMA market investigation. You don’t need to decode lengthy legal orders (Parts 3 to 8 of the 2019 Order) or hunt for compliance deadlines. We deliver clear, actionable info.

Halfway through your SEIS/EIS journey, you deserve a partner who’s aligned with post-investigation best practices. Explore how Oriel IPO stays ahead in CMA market investigation compliance


4. Comparing Oriel IPO to Other SEIS/EIS Platforms

There are many names out there, each with pros and cons:

  • Seedrs
    Strength: Broad equity crowdfunding network.
    Limitation: Standard transaction fees and less targeted SEIS/EIS screening.
  • Crowdcube
    Strength: Established platform, transparent pitch process.
    Limitation: Service fees reduce investor returns.
  • InvestingZone
    Strength: Focus on EIS/SEIS deals only.
    Limitation: Limited educational material on compliance reporting.
  • Crowd for Angels
    Strength: Low entry point, no investor fees.
    Limitation: Open platform, fewer curated vetting stages.

Oriel IPO stands out by combining the best of these features with the compliance rigour highlighted by the CMA market investigation, all without cutting into the funds you raise or invest.


5. Practical Steps for SEIS/EIS Investors Post-Investigation

You don’t need to be a compliance expert to benefit. Follow these steps:

  1. Review fee structures: Ask your chosen platform to itemise all charges.
  2. Demand vetting reports: Make sure every opportunity you back has passed a quality check.
  3. Check compliance updates: See when your platform last filed CMA statements.
  4. Understand your rights: Read up on the 2019 Order’s key parts (Articles 3 to 13).
  5. Use educational tools: Leverage webinars and guides to navigate SEIS/EIS requirements.

By taking control this way, you steer clear of hidden fees and align with the transparency goals of the CMA market investigation.


Testimonials

“Switching to Oriel IPO was a game-changer. Their clear fee breakdown made me confident I’d get full tax relief benefits on my SEIS investments.”
— Jane Marshall, Angel Investor

“I appreciate knowing that every startup listing on Oriel IPO meets strict SEIS/EIS criteria. No surprises, no extra charges.”
— Alex Patel, Early-stage Backer

“Oriel IPO’s webinars helped me understand the FCA and CMA rules. I feel much more in control of my portfolio.”
— Sophie Grant, Portfolio Manager


Conclusion

The CMA market investigation reshaped how investors and startups interact with consultants and platforms. It underscored the need for fee transparency, robust vetting and reliable compliance reporting. For SEIS/EIS investors, that’s a win: better insight and fewer hidden costs.

If you’re ready to back early-stage businesses with clarity and peace of mind, there’s one place to start. Empower your SEIS/EIS strategy amid the CMA market investigation

more from this section